ImageneBio (IMA) Cash from Financing Activities (2020 - 2025)

ImageneBio has disclosed Cash from Financing Activities across 5 years of filings, most recently posting $27000.0 for Q1 2025.

• Cash from Financing Activities for Q1 2025 came in at $27000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $39.0 million (changed N/A YoY), and the FY2023 annual result was $76.0 million, up 6838.81% from the prior year.
• Cash from Financing Activities came in at $27000.0 for Q1 2025 at ImageneBio, down from $60000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $132.5 million in Q1 2021 to a low of -$1.1 million in Q2 2021.
• The 4-year median for Cash from Financing Activities is $69000.0 (2021), against an average of $15.6 million.
• Peak annual rise in Cash from Financing Activities reached 630985.71% in 2021, while the deepest fall reached 99.8% in 2021.
• ImageneBio's Cash from Financing Activities stood at $236000.0 in 2021, then tumbled by 99.58% to $1000.0 in 2022, then jumped by 5900.0% to $60000.0 in 2023, then sank by 55.0% to $27000.0 in 2025.
• The last three Cash from Financing Activities figures came in at $27000.0 (Q1 2025), $60000.0 (Q4 2023), and $38.9 million (Q3 2023), per Business Quant data.